Trans-4-ethoxyphenyl 4-butylcyclohexanecarboxylate, 97.0%, 10g

3-(2,4-dimethylphenyl)-2-sulfanylideneimidazolidin-4-one, 100mg

1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidine-3-carboxylic acid, 95.0%, 250mg

D(+)-Galactosa, 10 g

Ethyl(1S,3S,4S)-4-fluoro-3-hydroxycyclohexane-1-carboxylate, 98%, 5g

1-(tert-Butyl)-4,4-diphenylpiperidine, 95.0%, 1g

(2-Methylpyrimidin-5-yl)methanamine, 95.0%, 500mg

3,5-Dimethyl-1H-pyrazole-4-carboxylic acid, 97.0%, 25g

3-(4-ethoxyphenyl)-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 250mg

Hydroxypropyl Acrylate (mixture of 2-Hydroxypropyl and 2-Hydroxy-1-methylethyl Acrylate) (stabilized with MEHQ)>90.0%(GC)500mL

4-Ethylcyclohexanecarboxylic Acid (cis- and trans- mixture)>98.0%(GC)(T)5g

Dimethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2,6-dicarboxylate, 95.0%, 1g

2-Chloro-6-fluorobenzaldehyde>95.0%(GC)10g